MXCT - MaxCyte GAAP EPS of -$0.04 beats by $0.03 revenue of $11.6M beats by $3.1M May, 09 2022 04:29 PM MaxCyte Inc. MaxCyte press release (NASDAQ:MXCT): Q1 GAAP EPS of -$0.04 beats by $0.03. Revenue of $11.6M (+78.5% Y/Y) beats by $3.1M. For further details see: MaxCyte GAAP EPS of -$0.04 beats by $0.03, revenue of $11.6M beats by $3.1M